招商局中國基金(00133.HK):天正轉讓所持有的全部金瀾湄旅遊20%股權
格隆匯6月4日丨招商局中國基金(00133.HK)發佈公告,關於公司的全資附屬公司深圳市天正投資有限公司(“天正”)簽署了關於雲南金瀾湄國際旅遊投資開發有限公司(“金瀾湄旅遊”)的合資協議的公告。根據該合資協議,天正承諾總共出資2000萬元人民幣,並持有金瀾湄旅遊20%的股權。而天正按約定出資進度最終實際出資1000萬元人民幣。
天正近期完成了關於金瀾湄旅遊的股權轉讓交易。根據有關交易,天正轉讓了所持有的全部金瀾湄旅遊20%股權予金瀾湄旅遊另一股東,並收回股權轉讓價款約279萬元人民幣。公司認爲,轉讓金瀾湄旅遊股權可讓公司及時止損並收回部分投資本金,對公司及其股東而言實屬有利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.